Target identification is a fundamental first step in drug discovery, involving the discovery and validation of disease-associated molecular mechanism that can be modulated by a drug. In this whitepaper we introduce Evotec's PanOmics TargetID Framework developed by the Bioinformatics and Computational Biology teams. It is a modular system that uses computational tools coupled with expert assessments to identify and rank potential drug targets. Our framework delivers a comprehensive report with a list of disease-relevant targets, their scores, annotations, rankings, and detailed information on their druggability, biology, safety, competition, and efficacy..
